Bio-Rad Laboratories (BIO) Short Interest Ratio & Short Volume → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free BIO Stock Alerts $277.80 +2.20 (+0.80%) (As of 01:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Bio-Rad Laboratories Short Interest DataCurrent Short Volume688,500 sharesPrevious Short Volume564,800 sharesChange Vs. Previous Month+21.90%Dollar Volume Sold Short$206.83 millionShort Interest Ratio / Days to Cover3.3Last Record DateApril 15, 2024Outstanding Shares28,520,000 sharesFloat Size19,690,000 sharesShort Percent of Float3.50%Today's Trading Volume49,666 sharesAverage Trading Volume201,332 sharesToday's Volume Vs. Average25% Short Selling Bio-Rad Laboratories ? Sign up to receive the latest short interest report for Bio-Rad Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIO Short Interest Over TimeBIO Days to Cover Over TimeBIO Percentage of Float Shorted Over Time Ad DTIWhat is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. Bio-Rad Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024688,500 shares $206.83 million +21.9%3.5%3.3 $300.41 3/31/2024564,800 shares $195.35 million -2.5%2.9%2.8 $345.87 3/15/2024579,300 shares $193.20 million +15.1%2.9%2.9 $333.51 2/29/2024503,400 shares $164.05 million -14.3%2.5%2.2 $325.88 2/15/2024587,100 shares $193.18 million +11.5%3.0%2.5 $329.04 1/31/2024526,700 shares $169.01 million +1.0%2.6%2 $320.89 Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024521,300 shares $166.07 million +15.0%2.6%1.8 $318.56 12/31/2023453,400 shares $146.40 million -9.9%2.2%1.6 $322.89 12/15/2023503,300 shares $154.07 million -22.5%2.5%1.8 $306.12 11/30/2023649,300 shares $198.13 million +13.5%3.2%2.6 $305.14 11/15/2023572,100 shares $175.57 million +36.9%2.8%2.4 $306.89 10/31/2023418,000 shares $115.06 million +23.9%2.0%2.1 $275.27 10/15/2023337,300 shares $116.28 million +1.8%1.7%1.8 $344.73 9/30/2023331,500 shares $118.83 million -14.7%1.6%1.9 $358.45 9/15/2023388,500 shares $146.17 million -10.7%1.9%2.1 $376.23 8/31/2023435,100 shares $174.13 million +6.3%2.1%2.2 $400.20 8/15/2023409,500 shares $161.70 million +21.8%2.0%1.9 $394.88 7/31/2023336,300 shares $136.30 million +1.1%1.6%1.3 $405.28 7/15/2023332,800 shares $131.98 million +17.6%1.6%1.5 $396.57 6/30/2023283,100 shares $107.27 million +0.6%1.4%1.4 $378.90 6/15/2023281,400 shares $106.67 million -26.7%1.3%1.4 $379.06 5/31/2023383,800 shares $143.29 million +31.8%1.8%2 $373.35 5/15/2023291,200 shares $111.17 million +23.2%1.4%1.5 $381.75 4/30/2023236,400 shares $106.57 million -13.9%1.1%1.3 $450.79 4/15/2023274,400 shares $131.51 million +3.5%1.3%1.7 $479.25 3/31/2023265,200 shares $127.04 million -26.8%1.3%1.6 $479.02 3/15/2023362,400 shares $173.23 million +29.9%1.7%2.2 $478.00 2/28/2023279,000 shares $133.32 million +13.8%1.3%1.7 $477.84 2/15/2023245,100 shares $112.87 million -1.9%1.2%1.5 $460.52 1/31/2023249,900 shares $116.82 million -10.1%1.2%1.4 $467.46 1/15/2023278,100 shares $126.59 million +10.1%1.3%1.3 $455.20 12/30/2022252,500 shares $106.17 million +8.8%1.2%1.1 $420.49 12/15/2022232,100 shares $97.59 million +17.2%1.1%0.9 $420.48 11/30/2022198,100 shares $82.15 million -30.3%0.9%0.8 $414.71 11/15/2022284,100 shares $119.64 million +12.7%1.3%1.2 $421.11 10/31/2022252,000 shares $88.63 million +1.3%1.2%1.2 $351.71 10/15/2022248,800 shares $98.20 million -17.7%1.2%1.4 $394.71 9/30/2022302,400 shares $126.14 million -20.1%1.4%1.9 $417.14 9/15/2022378,400 shares $178.89 million +2.9%1.8%2.6 $472.75 8/31/2022367,600 shares $178.30 million +24.0%1.7%2.5 $485.04Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now BIO Short Interest - Frequently Asked Questions What is Bio-Rad Laboratories' current short interest? Short interest is the volume of Bio-Rad Laboratories shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 688,500 shares of BIO short. 3.50% of Bio-Rad Laboratories' shares are currently sold short. Learn More on Bio-Rad Laboratories' current short interest. What is a good short interest ratio for Bio-Rad Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIO shares currently have a short interest ratio of 3.0. Learn More on Bio-Rad Laboratories's short interest ratio. Which institutional investors are shorting Bio-Rad Laboratories? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bio-Rad Laboratories: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bio-Rad Laboratories? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.50% of Bio-Rad Laboratories' floating shares are currently sold short. Is Bio-Rad Laboratories' short interest increasing or decreasing? Bio-Rad Laboratories saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 688,500 shares, an increase of 21.9% from the previous total of 564,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bio-Rad Laboratories' float size? Bio-Rad Laboratories currently has issued a total of 28,520,000 shares. Some of Bio-Rad Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bio-Rad Laboratories currently has a public float of 19,690,000 shares. How does Bio-Rad Laboratories' short interest compare to its competitors? 3.50% of Bio-Rad Laboratories' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Bio-Rad Laboratories: Waters Co. (6.66%), Illumina, Inc. (3.31%), Revvity, Inc. (2.93%), 10x Genomics, Inc. (7.44%), Olink Holding AB (publ) (2.20%), Avantor, Inc. (4.07%), Encompass Health Co. (2.23%), Penumbra, Inc. (5.01%), Ascendis Pharma A/S (6.18%), Legend Biotech Co. (6.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Bio-Rad Laboratories stock? Short selling BIO is an investing strategy that aims to generate trading profit from Bio-Rad Laboratories as its price is falling. BIO shares are trading up $2.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bio-Rad Laboratories? A short squeeze for Bio-Rad Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIO, which in turn drives the price of the stock up even further. How often is Bio-Rad Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: WAT Short Interest Data ILMN Short Interest Data RVTY Short Interest Data TXG Short Interest Data OLK Short Interest Data AVTR Short Interest Data EHC Short Interest Data PEN Short Interest Data ASND Short Interest Data LEGN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings